Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential trial of intravitreal bevacizumab rescue for recurrent macular edema after Ozurdex in retinal vein occlusion
2012-000165-20Phase 2Completed
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Jan 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab in Vein occlusion (RVO), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoints: Visual acuity improvement and Foveal thickness reduction. Started Jan 2012; status: completed.
02
Drugs
bevacizumab
03
Conditions
Vein occlusion (RVO)
Beyond the preview
Go deeper on 2012-000165-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000165-20.